Adenine Deoxy Nucleoside

Also known as: Adenine Deoxyribonucleoside Adenine Deoxyribose Adenine Nucleoside Adenine Riboside Adenosine Adenyldeoxyriboside Deoxyadenosine Desoxyadenosine

Active ingredient description

Adenosine is a purine nucleoside which is present in all cells of the body. Animal pharmacology studies have in several species shown that adenosine has a negative dromotropic effect on the atrioventricular (AV) node.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Adenosine
C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB10

Medicines

Adenine Deoxy Nucleoside is the active ingredient of these drugs:

Drug
Countries

Brazil Canada United States

Ireland Lithuania Netherlands New Zealand Poland

France Hong Kong Spain United Kingdom

Lithuania

France Tunisia

Spain

France

Brazil

France

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Structured Product Labeling (SPL)
US

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

K72T3FS567 - ADENOSINE

CAS registry number

58-61-7 - Adenosine

SNOMED-CT

35431001 - Adenosine (substance)